4743 studies found for:    HER2 and imaging
Show Display Options
Rank Status Study
1 Completed Biodistribution and Dosimetry of Serial PET Imaging With Ga-68 Labeled F(ab') 2- Trastuzumab
Condition: Solid Tumors
Intervention: Radiation: PET Imaging with Ga-68 Labeled F(ab') 2- Trastuzumab
2 Recruiting Magnetic Resonance Elastography and 2-Point Dixon MR Imaging Techniques in Diffuse Liver Disease
Condition: Liver Cancer
Interventions: Procedure: Magnetic Resonance Elastogram;   Procedure: 2-Point Dixon Magnetic Resonance Imaging
3 Recruiting Pilot Imaging Study With 89Zr-Trastuzumab in HER2-positive Metastatic Breast Cancer Patients
Conditions: Breast Neoplasms;   Secondary;   HER2 Positive Carcinoma of Breast
Intervention: Drug: Zr89-trastuzumab
4 Completed PET Imaging of Cannabinoid CB1 Receptors Using [18F]FMPEP-d2
Conditions: CB1;   Cannabinoid;   PET;   [18F]FMPEP-d2;   Brain Imaging
Intervention: Drug: [18F]FMPEP-d2
5 Enrolling by invitation Is Any Additional Information Gained Regarding Margins Using 3D Tomosynthesis Vs 2D Conventional Digital Imaging When Imaging Operative Breast Specimens?
Condition: Breast Cancer
Interventions: Radiation: 3 dimensional tomosynthesis imaging;   Radiation: 2 dimensional digital imaging
6 Recruiting Phase I/IIA Study of PET Imaging With 89Zr-Df-IAB2M in Metastatic Prostate Cancer
Condition: Metastatic Prostate Cancer
Intervention: Biological: [89Zr]Df-IAB2M
7 Recruiting HER2 PET Imaging in Breast Cancer Patients Using [68GA]ABY-025
Condition: HER2-positive Breast Cancer
Intervention: Other: Radiolabeled  [68Ga]ABY-025
8 Recruiting 18F FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy
Conditions: Adult Giant Cell Glioblastoma;   Adult Glioblastoma;   Adult Gliosarcoma;   Male Breast Cancer;   Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma;   Recurrent Adenoid Cystic Carcinoma of the Oral Cavity;   Recurrent Adult Brain Tumor;   Recurrent Basal Cell Carcinoma of the Lip;   Recurrent Breast Cancer;   Recurrent Colon Cancer;   Recurrent Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity;   Recurrent Hypopharyngeal Cancer;   Recurrent Inverted Papilloma of the Paranasal Sinus and Nasal Cavity;   Recurrent Laryngeal Cancer;   Recurrent Lip and Oral Cavity Cancer;   Recurrent Lymphoepithelioma of the Nasopharynx;   Recurrent Lymphoepithelioma of the Oropharynx;   Recurrent Metastatic Squamous Neck Cancer With Occult Primary;   Recurrent Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity;   Recurrent Mucoepidermoid Carcinoma of the Oral Cavity;   Recurrent Nasopharyngeal Cancer;   Recurrent Non-small Cell Lung Cancer;   Recurrent Oropharyngeal Cancer;   Recurrent Pancreatic Cancer;   Recurrent Paranasal Sinus and Nasal Cavity Cancer;   Recurrent Rectal Cancer;   Recurrent Renal Cell Cancer;   Recurrent Salivary Gland Cancer;   Stage IIIA Breast Cancer;   Stage IIIA Non-small Cell Lung Cancer;   Stage IIIB Breast Cancer;   Stage IIIB Non-small Cell Lung Cancer;   Stage IIIC Breast Cancer;   Stage IV Breast Cancer;   Stage IV Non-small Cell Lung Cancer;   Stage IV Pancreatic Cancer;   Stage IV Renal Cell Cancer;   Stage IVA Colon Cancer;   Stage IVA Rectal Cancer;   Stage IVA Salivary Gland Cancer;   Stage IVB Colon Cancer;   Stage IVB Salivary Gland Cancer;   Stage IVC Salivary Gland Cancer;   Tongue Cancer;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Radiation: fludeoxyglucose F 18;   Radiation: 2-fluoropropionyl-labeled pegylated dimeric RGD peptide;   Procedure: positron emission tomography;   Procedure: computed tomography;   Other: laboratory biomarker analysis
9 Recruiting IMaging PAtients for Cancer Drug selecTion - Metastatic Breast Cancer
Condition: Metastatic Breast Cancer
Intervention: Procedure: Molecular imaging
10 Recruiting Carboplatin+Nab-paclitaxel, Plus Trastuzumab (HER2+) or Bevacizumab (HER2-) in the Neoadjuvant Setting
Conditions: Breast Cancer;   HER2-negative Breast Cancer;   HER2-positive Breast Cancer;   Recurrent Breast Cancer;   Stage IA Breast Cancer;   Stage IB Breast Cancer;   Stage II Breast Cancer;   Stage IIIA Breast Cancer;   Stage IIIB Breast Cancer;   Stage IIIC Breast Cancer
Interventions: Drug: Carboplatin;   Drug: paclitaxel albumin-stabilized nanoparticle formulation;   Drug: bevacizumab;   Drug: trastuzumab;   Procedure: magnetic resonance imaging;   Procedure: therapeutic conventional surgery
11 Recruiting Fluorescence & Reflectance Imaging to Detect Oral Neoplasia
Condition: Oral Cancer
Interventions: Procedure: Portable Spectroscopy System;   Procedure: Multispectral Digital Microscope;   Procedure: Fast Excitation-Emission Matrix System
12 Completed PET Imaging With Cu-64 Labeled Trastuzumab in HER2+ Metastatic Breast Cancer
Condition: Breast Cancer
Intervention: Radiation: PET Imaging With Cu-64 Labeled Trastuzumab
13 Recruiting PET Imaging of Extrathalamic α4β2-nicotinic Acetylcholine Receptors in Health and Disease With [18F]XTRA
Condition: Measure of Uptake of XTRA in the Brain.
Intervention: Radiation: Positron Emission Tomagraphy (PET) Imaging
14 Recruiting CO2 as a Stress Agent for Perfusion Imaging
Condition: Coronary Artery Disease
Interventions: Device: Delivery of precise levels of carbon dioxide with the RespirAct™ Gen4 sequential gas delivery system;   Device: Delivery of rubidium radioisotope (Rb-82) using the automated pump/elution system
15 Unknown  Two Separate But Identical Studies Evaluating the Safety and Efficacy of ALTROPANE® in the Use of SPECT Imaging for Upper Extremity Tremor
Condition: Parkinsonian Syndromes
Intervention: Drug: 123 I - ALTROPANE®
16 Completed
Has Results
Effect of Ranolazine on Myocardial Perfusion Assessed by Serial Quantitative Exercise SPECT Imaging
Conditions: Myocardial Perfusion Imaging;   Myocardial Ischemia
Interventions: Drug: Ranolazine;   Drug: Placebo to match ranolazine;   Procedure: SPECT MPI;   Behavioral: Exercise
17 Recruiting Clinical Evaluation of Magnetic Resonance Imaging in Coronary Heart Disease-2
Condition: Coronary Heart Disease
Interventions: Other: 3T CMR;   Other: SPECT;   Other: CT calcium score;   Other: CT coronary angiography;   Other: X-Ray coronary angiography
18 Recruiting HER2 Imaging Study to Identify HER2 Positive Metastatic Breast Cancer Patient Unlikely to Benefit From T-DM1
Condition: HER-2 Positive Breast Cancer
Interventions: Drug: T-DM1;   Procedure: 89Zr-trastuzumab
19 Recruiting SILO2 (Signal Intensity Lung washOut)
Condition: Chronic Obstructive Pulmonary Disease
Intervention: Other: MRI lung imaging (not an intervention per se but the focus of the study)
20 Recruiting T2 Weighted Imaging of the Liver With Fast Spin Echo MRI
Condition: Liver Disease
Intervention: Device: MRI examinations

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years